Terms ending in 2033
Every in-force patent on Ono Pharmaceutical Co., Ltd.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,403,867 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 9,872,883 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 9,956,261 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 9,981,002 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,300,105 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,576,122 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,905,737 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 9,701,749 | Therapeutic Agent for Autoimmune Diseases Comprising PD-1 Agonist In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,647,770 | Therapeutic Agent for Autoimmune Diseases Comprising PD-1 Agonist In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.